NASDAQ:CALA - Calithera Biosciences Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$4.75 -0.10 (-2.06 %)
(As of 07/16/2018 04:53 AM ET)
Previous Close$4.75
Today's Range$4.65 - $4.80
52-Week Range$4.30 - $20.05
Volume180,536 shs
Average Volume438,468 shs
Market Capitalization$170.26 million
P/E Ratio-5.65
Dividend YieldN/A
Beta2.53

Analyst Ratings

Calithera Biosciences (NASDAQ:CALA) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Calithera Biosciences in the last 12 months. Their average twelve-month price target is $14.00, suggesting that the stock has a possible upside of 194.74%. The high price target for CALA is $14.00 and the low price target for CALA is $14.00. There are currently 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.002.83
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $14.00$14.00$17.6667$14.40
Price Target Upside: 194.74% upside156.88% upside224.16% upside9.15% downside

Calithera Biosciences (NASDAQ:CALA) Consensus Price Target History

Price Target History for Calithera Biosciences (NASDAQ:CALA)

Calithera Biosciences (NASDAQ:CALA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/6/2018Leerink SwannReiterated RatingOutperformMediumView Rating Details
2/16/2018CitigroupUpgradeNeutral ➝ Buy$6.95 ➝ $14.00HighView Rating Details
10/5/2017William BlairInitiated CoverageOutperform ➝ OutperformN/AView Rating Details
6/12/2017HC WainwrightReiterated RatingBuy$14.00 ➝ $19.00LowView Rating Details
6/6/2017Wells Fargo & CoReiterated RatingOutperform$15.00 ➝ $20.00HighView Rating Details
3/28/2017JMP SecuritiesReiterated RatingOutperform$12.00 ➝ $12.00MediumView Rating Details
(Data available from 7/16/2016 forward)
This page was last updated on 7/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.